(Q40596089)

21 September 2017

1 reference

title

Microneedle-mediated delivery of viral vectored vaccines (English)

1 reference

21 September 2017

author

Linda Sylvia Klavinskis

series ordinal

object named as

Linda Sylvia Klavinskis

1 reference

21 September 2017

Marija Zaric

1 reference

21 September 2017

Bárbara Ibarzo Yus

series ordinal

1 reference

21 September 2017

Petya Petrova Kalcheva

series ordinal

1 reference

21 September 2017

language of work or name

English

0 references

publication date

7 September 2016

1 reference

Expert Opinion on Drug Delivery

21 September 2017

published in

1 reference

21 September 2017

1 reference

21 September 2017

1 reference

21 September 2017

page(s)

1177-1187

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

21 September 2017

1 reference

Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Transdermal influenza immunization with vaccine-coated microneedle arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Immunological mechanisms of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Vaccine adjuvants: current state and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

How do adjuvants work? Important considerations for new generation adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Vaccine Adjuvants: Putting Innate Immunity to Work

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Targeted vaccine adjuvants based on modified cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Taking dendritic cells into medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Immunobiology of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Some interfaces of dendritic cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Steady-state and inflammatory dendritic-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Organization of the mouse and human DC network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

DC subsets in positive and negative regulation of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Dendritic-cell control of pathogen-driven T-cell polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Recognition of microorganisms and activation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Cross-presentation, dendritic cells, tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Cross-presentation: inducing CD8 T cell immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Viral vectors for vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Retracted: Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Construction and evaluation of novel rhesus monkey adenovirus vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Developments in Viral Vector-Based Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Viruses as vaccine vectors for infectious diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Novel Adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Oncolytic myxoma virus: the path to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Microneedle arrays as medical devices for enhanced transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Microneedles for drug and vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Microneedle-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Stability of influenza vaccine coated onto microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Effect of Osmotic Pressure on the Stability of Whole Inactivated Influenza Vaccine for Coating on Microneedles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Evaluation of heterosubtypic cross-protection against highly pathogenic H5N1 by active infection with human seasonal influenza A virus or trivalent inactivated vaccine immunization in ferret models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Vaccine delivery with microneedle skin patches in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Impact-insertion applicator improves reliability of skin penetration by solid microneedle arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Polymer multilayer tattooing for enhanced DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17425247.2017.1230096

10.1080/17425247.2017.1230096

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference